IntelliPharmaCeutics International Inc. IPCI was a big mover last session, as its shares rose nearly 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the stock as it is now trading over the volatile price range of $3.63 to $4.15 in the past one-month timeframe.
In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
IntelliPharmaCeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. WX, BioLineRx, Ltd. BLRX and Aratana Therapeutics, Inc. PETX. All three carry the same Zacks Rank as IntelliPharmaCeutics.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BIOLINE RX LTD BLRX: Get Free Report
INTELLIPHARMACT IPCI: Free Stock Analysis Report
ARATANA THERAP PETX: Free Stock Analysis Report
WUXI PHARMATECH WX: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
IntelliPharmaCeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. WX, BioLineRx, Ltd. BLRX and Aratana Therapeutics, Inc. PETX. All three carry the same Zacks Rank as IntelliPharmaCeutics.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BIOLINE RX LTD BLRX: Get Free Report
INTELLIPHARMACT IPCI: Free Stock Analysis Report
ARATANA THERAP PETX: Free Stock Analysis Report
WUXI PHARMATECH WX: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
